Habib J. Dable, CEO and President at ACCELERON PHARMA INC (XLRN), sold 14,674 shares at $44.60 ($654K) on 2019-04-09, disclosed to the SEC on 2019-04-11.
Open-market sale of $654k XLRN by CEO and President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.23 | 146 | $6K | 1.0% |
| 2 | $44.60 | 7,214 | $322K | 49.2% |
| 3 | $44.60 | 7,214 | $322K | 49.2% |
| 4 | $45.46 | 100 | $5K | 0.7% |
| Total | $44.60 avg | 14,674 | $654K | 100% |
| Filing → |
| XLRN | SELL | 2020-07-06 | $8.9M | — | Filing → |
| XLRN | SELL | 2020-01-03 | $377K | — | Filing → |
| XLRN | SELL | 2019-09-10 | $493K | — | Filing → |